ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,254.18
-0.76%
Dow Jones
38,860.99
-0.53%
Gold vs US Dollar
2,357.10
0.22%
Brent Oil
83.96
1.35%
Bitcoin
67,659.29
-2.50%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Arch Therapeutics Inc (QB) (ARTHD)

  7. Arch Therapeutics Inc (QB) (ARTHD) News

Arch Therapeutics (QB) (ARTHD)

Arch Therapeutics Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:ARTHD
DateTimeSourceHeadlineSymbolCompany
21/05/202421:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
09/05/202421:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ARTHDArch Therapeutics Inc (QB)
06/05/202421:36Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
03/04/202422:07Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
18/03/202420:29Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
01/03/202421:31Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
01/03/202421:30Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]USOTC:ARTHDArch Therapeutics Inc (QB)
20/02/202422:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ARTHDArch Therapeutics Inc (QB)
15/02/202421:30Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ARTHDArch Therapeutics Inc (QB)
07/02/202421:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
22/01/202417:39Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:ARTHDArch Therapeutics Inc (QB)
12/01/202421:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
11/01/202421:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
29/12/202321:30Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405USOTC:ARTHDArch Therapeutics Inc (QB)
15/12/202321:31Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
08/12/202321:34Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
22/11/202321:33Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
15/11/202321:47Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
09/11/202311:50Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
05/10/202322:27Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]USOTC:ARTHDArch Therapeutics Inc (QB)
04/10/202321:11Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
27/09/202322:12Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
13/09/202321:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
08/09/202322:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ARTHDArch Therapeutics Inc (QB)
08/09/202322:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ARTHDArch Therapeutics Inc (QB)
07/09/202321:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
06/09/202321:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
01/09/202321:30Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsUSOTC:ARTHDArch Therapeutics Inc (QB)
23/08/202313:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
22/08/202321:52Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsUSOTC:ARTHDArch Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:ARTHD

Your Recent History

LSE
POS
Plexus
LSE
RR.
Rolls-royce
LSE
BP.
Bp
LSE
QED
Quadrise
LSE
INSP
Inspirit Energy
LSE
ITV
Itv
LSE
NG.
National Grid
LSE
ZED
Zenova
LSE
SAR
Sareum
LSE
VAST
Vast Resources
LSE
GPL
Graft Polymer (uk)
LSE
MIN
Minoan
LSE
TERN
Tern
LSE
BOO
Boohoo
LSE
QBT
Quantum Blockchain Techn...
LSE
EME
Empyrean Energy
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved